These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 7237956)

  • 41. [A new antibiotic in pediatrics].
    Lackner H; Streicher V
    Hospital (Rio J); 1968 Jun; 73(6):1859-65. PubMed ID: 5305591
    [No Abstract]   [Full Text] [Related]  

  • 42. [Action and tolerance of cephalexin in infectious processes of the upper respiratory tract in childhood. Apropos of 100 cases].
    Vazquez JR; Vecchio H; Ordoñez A
    Prensa Med Argent; 1971 Aug; 58(24):1242-6. PubMed ID: 5115409
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical evaluation of cefpiramide in pediatrics].
    Yanagisawa K; Hoshina H; Mikuni K; Ichihashi H
    Jpn J Antibiot; 1983 Aug; 36(8):2201-6. PubMed ID: 6655841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Laboratory and clinical study of cefamandole by intravenous injection in the pediatric field (author's transl)].
    Nakazawa S; Satoh H; Niino K; Nakazawa S; Suzuki H; Iwasaki A; Chikaoka H; Oka S; Hirama Y; Narita A
    Jpn J Antibiot; 1979 Nov; 32(11):1081-90. PubMed ID: 513290
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cephacetrile--a new cephalosporin antibiotic.
    Hodson AH; Holloway WJ
    Int J Clin Pharmacol; 1973 Feb; 7(1):89-94. PubMed ID: 4699390
    [No Abstract]   [Full Text] [Related]  

  • 46. [Results of a clinical trial of the use of a methoxyamine (cefuroxime) in respiratory tract infections in children].
    Castello D; Sacchetti L; Brero P; Poncini L
    Minerva Pediatr; 1981 Sep; 33(17):881-6. PubMed ID: 7031458
    [No Abstract]   [Full Text] [Related]  

  • 47. Is it reasonable to use cephalosporins in respiratory and upper tract renal infections in hospitalized patients?
    Perkins RL
    Bull N Y Acad Med; 1984 May; 60(4):403-15. PubMed ID: 6372916
    [No Abstract]   [Full Text] [Related]  

  • 48. [Double-blind comparison of cefamandole and cefazolin in the therapy of respiratory tract infections (author's transl)].
    Jpn J Antibiot; 1980 Mar; 33(3):375-409. PubMed ID: 6995640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cefamandole nafate therapy in the treatment of acute urinary tract infections.
    Short HD; Gentry LO; Sessoms S
    J Antimicrob Chemother; 1976 Dec; 2(4):345-50. PubMed ID: 802125
    [No Abstract]   [Full Text] [Related]  

  • 50. Second-generation cephalosporins.
    Glatt AE
    Hosp Pract (Off Ed); 1986 Mar; 21(3):158A-158B, 158E, 158H-158L. PubMed ID: 3081544
    [No Abstract]   [Full Text] [Related]  

  • 51. [Experience in pediatrics with a combination of ampicillin and flucloxacillin drops].
    Brogi G
    Minerva Pediatr; 1979 May; 31(10):813-8. PubMed ID: 470860
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical use of cefamandole: a new cephalosporin.
    Little PJ; Peddie BA; Pearson S
    Med J Aust; 1979 Feb; 1(3):97-9. PubMed ID: 431451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical evaluation of cefamandole in infants and children (author's transl)].
    Kuno K; Nishikawa K; Ogawa A; Yamaguchi H; Koide T; Kondo K
    Jpn J Antibiot; 1979 Sep; 32(9):952-5. PubMed ID: 387995
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cephamandole--pharmacokinetic, pharmacodynamic and clinical examinations (author's transl)].
    Car V; Schönwald S; Lenardic A; Gmajnicki B; Falisevac J
    Lijec Vjesn; 1979 Jun; 101(6):371-4. PubMed ID: 502719
    [No Abstract]   [Full Text] [Related]  

  • 55. Microbiological and clinical studies on cefpodoxime proxetil for bacterial skin and soft tissue infections in pediatric patients.
    Ito K; Ito M
    J Chemother; 1995 Nov; 7 Suppl 4():124-6. PubMed ID: 8904131
    [No Abstract]   [Full Text] [Related]  

  • 56. [Experience with the therapeutic use of cefuroxime in neonatology].
    Jafusco F; Ansanelli V; Di Lena C
    Pediatria (Napoli); 1981 Mar; 89(1):1-17. PubMed ID: 7290825
    [No Abstract]   [Full Text] [Related]  

  • 57. [Evaluation of the therapeutic effectiveness of a new antibiotic combination in some infections in infancy].
    Marchi C; Di Tullio MT
    Minerva Pediatr; 1974 Apr; 26(12):635-47. PubMed ID: 4456198
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparison of cefamandole nafate to cefamandole by microbiological assay.
    Winely CL; Spears JC; Scott JK
    Antimicrob Agents Chemother; 1979 Sep; 16(3):424-6. PubMed ID: 41479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Can we utilize current bacteriological diagnostic methods for the purpose of drug selection?].
    Dzierzanowska D
    Przegl Lek; 1984; 41(3):287-91. PubMed ID: 6739848
    [No Abstract]   [Full Text] [Related]  

  • 60. Cefamandole nafate: an evaluation of antibacterial activity, serum levels, clinical effect, and incidence of side reactions in 58 patients.
    Ekwall E; Holmgren EB; Lundbergh P; Svanbom M; Tunevall G
    Scand J Infect Dis; 1979; 11(2):135-9. PubMed ID: 462128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.